March 6, 2012
The Bridge Project collaboration between the Koch Institute at MIT and Dana Farber/Harvard Cancer Center (DF/HCC) awarded funding to four interdisciplinary teams on March 6, 2012. The teams will work together on two of the most lethal forms of cancer—pancreatic and glioblastoma, a type of brain cancer. The unprecedented clinical research effort awards teams made up of biologists, bioengineers and clinical researchers from both cancer centers. It is the most extensive collaboration of its kind between Boston's two National Cancer Institute (NCI)-designated cancer centers.